We serve Chemical Name:(6-chloropyridin-3-yl)-(2-methylphenyl)methanone CAS:872088-10-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(6-chloropyridin-3-yl)-(2-methylphenyl)methanone
CAS.NO:872088-10-3
Synonyms:2-methylphenyl-2-chloropyrid-5-ylketone
Molecular Formula:C13H10ClNO
Molecular Weight:231.67800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:347.4ºC at 760 mmHg
Density:1.225g/cm3
Index of Refraction:1.59
PSA:29.96000
Exact Mass:231.04500
LogP:3.27440
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methylphenyl-2-chloropyrid-5-ylketone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methylphenyl-2-chloropyrid-5-ylketone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methylphenyl-2-chloropyrid-5-ylketone Use and application,2-methylphenyl-2-chloropyrid-5-ylketone technical grade,usp/ep/jp grade.
Related News: Biogen hiked its revenue guidance for the year, saying it expects total sales of $10.65 billion to $10.85 billion this year. That’s up from its previous estimates of $10.45 billion to $10.75 billion. The new forecast assumes “modest” revenue from Aduhelm in 2021, ramping up thereafter, the company said. 4-{[4′-[(2-butyl-1-benzofuran-3-yl)methyl]-4-(3-phenylpropoxy)biphenyl-3-yl]amino}-4-oxobutanoic acid manufacturers J.P. Morgan and William Blair analysts still backed iRhythm for the long-term despite its recent challenges. William Blair analysts wrote that the company is still a leader of a cardiac monitoring market that is under 20% penetrated and valued at approximately $2 billion. [2-hydroxy-4-(3-trimethoxysilylpropoxy)phenyl]-phenylmethanone suppliers The results provided a formulation amenable to two dosage strengths by applying a proportional dosing weight method.” The product is currently in late-stage development with the New Drug Application filing expected in late 2021. Pyrimidine, 2,2′-(1,4-phenylene)bis[5-(4-methoxyphenyl)- vendor & factory.
